Related Experiment Video
Updated: Feb 14, 2026

Artificial Antigen Presenting Cell aAPC Mediated Activation and Expansion of Natural Killer T Cells
Published on: December 29, 2012
Natural and Artificial Hematopoietic Cell Reprogramming
Dong Yu1, Wenpei Liu1, Feng Liu1
1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine (Shanghai), Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Hematopoietic cell reprogramming converts one blood or immune cell into another, offering potential for disease understanding and therapies. Advances in technology are improving efficiency and clinical use, but challenges remain.
Area of Science:
- Hematology
- Immunology
- Cell Biology
- Regenerative Medicine
Background:
- Hematopoietic cell reprogramming involves converting one blood or immune cell type into another.
- This process is crucial for understanding hematopoiesis, disease mechanisms, and developing novel therapeutics.
- It occurs through transdifferentiation, dedifferentiation, or plasticity, influenced by various cues and stressors.
Purpose of the Study:
- To review the potential of hematopoietic cell reprogramming in advancing hematology and immunology.
- To discuss the mechanisms, challenges, and emerging strategies in cell conversion.
- To highlight the future prospects for personalized cell therapies.
Main Methods:
- Review of current literature on hematopoietic cell reprogramming.
- Analysis of advancements in multi-omics, gene editing, and chemical biology.
- Integration of artificial intelligence and single-cell analytics for protocol development.
Main Results:
- Hematopoietic cell reprogramming holds transformative potential for understanding blood cell development and immune disorders.
- Technological advancements are enhancing reprogramming efficacy and clinical translatability.
- Challenges include low efficiency, phenotype instability, and safety concerns.
Conclusions:
- Hematopoietic cell reprogramming offers promising avenues for personalized cell therapies in oncology, immunology, and regenerative medicine.
- Overcoming challenges in delivery, specificity, and long-term efficacy is key to clinical realization.
- Integration of cutting-edge technologies is essential for future progress.
Related Concept Videos
Natural and Artificial Concepts
Multipotency of Hematopoietic Stem Cells
Regulation of Hematopoietic Stem Cells
Somatic to iPS Cell Reprogramming
What is Natural Selection?
Nature and Nurture

